Translate
Jacobio Pharmaceuticals Group Co., Ltd.
About
Jacobio Pharmaceuticals Group Co., Ltd. — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 10 2026
Jacobio Announces 2025 Annual Results
Dec 21 2025
Jacobio Pharma Enters Global Exclusive License Agreement with AstraZeneca for Pan-KRAS Inhibitor JAB-23E73
Oct 24 2025
Jacobio Presents Pre-Clinical Data of Pan-KRAS Inhibitor (JAB-23E73) at AACR-NCI-EORTC International Conference
Oct 15 2025
Jacobio Pharma Announces Strategic Partnership with Oceanpine Capital to Focus on Core Oncology Pipeline
Sep 26 2025
Jacobio Chairman and Concerted Parties Increase Shareholding by Nearly HK$100 Million, Demonstrating Confidence in Long-term Growth
Recent Videos
Jacobio Pharmaceuticals Group Co. Ltd. 2025 annual report
Apr 24, 2026
Jacobio Pharmaceuticals (1167) | S&P and Nasdaq hit record highs on Iran war optimism | 16-04-2026
Apr 16, 2026
Jacobio Pharmaceuticals Group Co. Ltd. 2025 annual report
Mar 12, 2026
𝗔𝗦𝗧𝗥𝗔𝗭𝗘𝗡𝗘𝗖𝗔 & 𝗝𝗔𝗖𝗢𝗕𝗜𝗢 𝗣𝗔𝗥𝗧𝗡𝗘𝗥 $𝟮𝗕 𝗣𝗔𝗡-𝗞𝗥𝗔𝗦 𝗗𝗘𝗔𝗟: 𝗙𝗨𝗧𝗨𝗥𝗘 𝗢𝗙 𝗖𝗔𝗡𝗖𝗘𝗥 𝗧𝗛𝗘𝗥𝗔𝗣𝗬 𝗘𝗫𝗣𝗟𝗔𝗜𝗡𝗘𝗗
Feb 13, 2026